TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
MedPlus Health Services Ltd. ( (IN:MEDPLUS) ) has issued an announcement.
MedPlus Health Services Ltd. announced that its subsidiary, Optival Health Solutions Private Limited, has received two suspension orders for a Drug License at its Telangana stores. The suspensions, issued by the Drugs Control Administration, Medchal, are due to violations under the Drugs and Cosmetics Act, 1940 and Rules, 1945. The suspensions are expected to result in a potential revenue loss of approximately Rs 0.48 lacs and Rs 1.28 lacs for the affected stores. This development may impact the company’s financial operations and highlights regulatory compliance challenges within the industry.
More about MedPlus Health Services Ltd.
MedPlus Health Services Ltd. operates in the healthcare industry, primarily focusing on providing pharmaceutical products and health-related services. The company is known for its extensive network of retail pharmacy outlets across India, catering to a wide range of healthcare needs.
Average Trading Volume: 21,259
Technical Sentiment Signal: Sell
Current Market Cap: 91.48B INR
For a thorough assessment of MEDPLUS stock, go to TipRanks’ Stock Analysis page.